These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 31322262)
1. MicroRNA‑198 suppresses prostate tumorigenesis by targeting MIB1. Ray J; Hoey C; Huang X; Jeon J; Taeb S; Downes MR; Boutros PC; Liu SK Oncol Rep; 2019 Sep; 42(3):1047-1056. PubMed ID: 31322262 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4. Kang Y; Zhang Y; Sun Y Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982769 [TBL] [Abstract][Full Text] [Related]
3. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way. Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer. Li T; Xing Y; Yang F; Sun Y; Zhang S; Wang Q; Zhang W Cancer Med; 2020 Jun; 9(11):3852-3862. PubMed ID: 32248648 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑195‑5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1. Chen B; Bai G; Ma X; Tan L; Xu H Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698358 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer. Yuan Y; Chen X; Huang E Technol Cancer Res Treat; 2019; 18():1533033819886867. PubMed ID: 31694481 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN. Wei D; Miao Y; Yu L; Wang D; Wang Y Mol Med Rep; 2018 Jul; 18(1):595-602. PubMed ID: 29749457 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [TBL] [Abstract][Full Text] [Related]
10. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer. Zhang X; Wang Y; Ning Y Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181 [TBL] [Abstract][Full Text] [Related]
12. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer. Shao N; Ma G; Zhang J; Zhu W BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516 [TBL] [Abstract][Full Text] [Related]
13. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma. Dankert JT; Wiesehöfer M; Wach S; Czyrnik ED; Wennemuth G Sci Rep; 2020 Oct; 10(1):18022. PubMed ID: 33093529 [TBL] [Abstract][Full Text] [Related]
14. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR. Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503. Qi H; Wen B; Wu Q; Cheng W; Lou J; Wei J; Huang J; Yao X; Weng G Biomed Pharmacother; 2018 Jun; 102():326-332. PubMed ID: 29571017 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑198 contributes to lupus nephritis progression by inhibition of phosphatase and tensin homology deleted on chromosome ten expression. Cui D; Zhu D; Ren H; Lin J; Lai W; Huang Q; Zhao J; Yang M Mol Med Rep; 2017 Nov; 16(5):7813-7820. PubMed ID: 28944868 [TBL] [Abstract][Full Text] [Related]
17. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5. Zheng C; Guo K; Chen B; Wen Y; Xu Y Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941 [TBL] [Abstract][Full Text] [Related]
18. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. Fort RS; Mathó C; Geraldo MV; Ottati MC; Yamashita AS; Saito KC; Leite KRM; Méndez M; Maedo N; Méndez L; Garat B; Kimura ET; Sotelo-Silveira JR; Duhagon MA BMC Cancer; 2018 Feb; 18(1):127. PubMed ID: 29394925 [TBL] [Abstract][Full Text] [Related]
19. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis. Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443 [TBL] [Abstract][Full Text] [Related]
20. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]